Lidya Genomics

Lidya Genomics builds the AI that turns the genome into clinical answers.

We develop research-grade, AI-driven platforms that help clinicians read genetic data with speed and precision — so that a diagnosis arrives sooner and a health decision is better informed. Our technology is used by clinics, hospitals, genetic diagnosis centers, and physicians to understand conditions, guide treatment, and improve outcomes for the patients in their care.

Our products:

- Genesus — our AI platform for rare and inherited disease, translating complex genomic signals into confident, actionable findings that shorten the road to diagnosis.

- Bioritma — genetic health check-ups that give people a clear, personalized picture of their health, and the guidance to act on it.

Everything we build rests on peer-reviewed science. The team behind Lidya has authored 11 publications in leading journals, including Nature Communications — the kind of rigor our clinical partners depend on and what sets our work apart.

We're building the diagnostic infrastructure for a future where every patient benefits from their own genome: earlier answers, smarter treatment decisions, and healthier lives.

If you're a clinic-owner, business partner, or scientist who wants to move genomic medicine forward, we'd like to hear from you.